Microba Life Sciences News and Activities

Microba Life Sciences is a company listed under the stock ticker MAP (AU).

View the org chart displaying its 18 main executives

Most searched biographies at Microba Life Sciences

• Luke Reid, Chief Executive Officer and Director
• Pasquale Rombola, Chairman of the Board
• Ian Frazer, Deputy Chairman of the Board

Create your alert
to follow the executive moves at Microba Life Sciences.

Microba Life Sciences has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).
• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Microba Life Sciences

• Successful IBD Phase I Clinical Trial
• Latest news
• Successful completion of Autoimmune Program with Ginkgo Bioworks
• Microba launches next generation healthcare testing with MetaXplore™ range

Social media about Microba Life Sciences

• Microba Life Sciences on Wikipedia, Google News & Yahoo Finance
• Microba Life Sciences on LinkedIn, X (Twitter) & YouTube